Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Brain Neoplasms 4Prostatic Neoplasms 3Neoplasms 3Breast Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Pinealoma 1Parotid Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Multiple Sclerosis 1Meningioma 1Meningeal Neoplasms 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Hypoxia 1Gynecologic Cancer 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Digestive System Diseases 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Astrocytoma 1

Interventions

Cisplatin 178Paclitaxel 79Radiotherapy 76Carboplatin 70Brachytherapy 69pembrolizumab 63Bevacizumab 40Gemcitabine 28Radiation 27Topotecan 26Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 25Nivolumab 22Colposcopy 22human papillomavirus vaccine, L1 type 16, 18 21Magnetic Resonance Spectroscopy 21Drug Therapy 20atezolizumab 19Platinum 19Papillomavirus Vaccines 18Radiotherapy, Intensity-Modulated 17Docetaxel 17Taxes 16Cyclophosphamide 16Biopsy 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14Blood Specimen Collection 14fludarabine 13Injections 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Neoplasms × gadobutrol × Clear all
NCT04219904 2026-05-20

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
25 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡